Table 1.
Study patient characteristics
| Total (n=13) | |
|---|---|
| Age (years), mean (SD) | 54.92 (9.58) |
| Sex, n (%) | |
| Male | 8 (61.5) |
| Female | 5 (38.5) |
| Primary tumor site, n (%) | |
| Bladder | 13 (100) |
| Pelvic ureter | 0 |
| Histological, n (%) | |
| Urothelial | 11 (84.6) |
| Mixed | 2 (15.4) |
| Leukocyte (×103/µL), median (minimum-maximum) | |
| First visit | 27.8 (20.8-51.3) |
| Second visit | 30.1 (20.0-66.8) |
| Neutrophil (×103/µL), median (minimum-maximum) | |
| First visit | 26.61 (16.6-84.6) |
| Second visit | 27.4 (17.1-61.9) |
| Lymphocyte (×103/µL), median (minimum-maximum) | |
| First visit | 1.2 (0.3-7.5) |
| Second visit | 1.34 (0.42-5.4) |
| NLR | |
| First visit | 23.125 (5.24-65.87) |
| Second visit | 21.375 (7.83-130.81) |
| Hemoglobin (g/dL), mean (SD) | 7.61 (1.73) |
SD: Standard deviation, NLR: Neutrophil-to-lymphocyte ratio